[go: up one dir, main page]

UA27099C2 - Склад для протипухлиhhої терапії у формі розчиhу, спосіб його одержаhhя та лікарський засіб для протипухлиhhої терапії - Google Patents

Склад для протипухлиhhої терапії у формі розчиhу, спосіб його одержаhhя та лікарський засіб для протипухлиhhої терапії

Info

Publication number
UA27099C2
UA27099C2 UA93002241A UA93002241A UA27099C2 UA 27099 C2 UA27099 C2 UA 27099C2 UA 93002241 A UA93002241 A UA 93002241A UA 93002241 A UA93002241 A UA 93002241A UA 27099 C2 UA27099 C2 UA 27099C2
Authority
UA
Ukraine
Prior art keywords
drug
antitumor therapy
solution
obtaining
antitumor
Prior art date
Application number
UA93002241A
Other languages
English (en)
Russian (ru)
Inventor
Юрген ЕHГЕЛ
Елізабет ВОЛЬФ-ХЕУСС
Хельмут ОРТХ
Буркхард ВІШЕРТ
Дітер ЗАУЕРБ'ЄР
Original Assignee
Аста Медіка Акціенгезельшафт
Аста Медика Акциенгезельшафт
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Аста Медіка Акціенгезельшафт, Аста Медика Акциенгезельшафт filed Critical Аста Медіка Акціенгезельшафт
Publication of UA27099C2 publication Critical patent/UA27099C2/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Luminescent Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Даний винахід належить до медицини і стосується онкологіі, способу одержання лікарського засобу для протипухлинної терапії. Склад для протипухлинної терапії в формі розчину містить алкілфосфохолін, алкілгліцериновий ефір воду і цитратний буфер.
UA93002241A 1992-10-23 1993-10-21 Склад для протипухлиhhої терапії у формі розчиhу, спосіб його одержаhhя та лікарський засіб для протипухлиhhої терапії UA27099C2 (uk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4235911A DE4235911A1 (de) 1992-10-23 1992-10-23 Stabilisierte Hexadecylphosphocholinlösungen in Glycerinalkylethern

Publications (1)

Publication Number Publication Date
UA27099C2 true UA27099C2 (uk) 2000-02-28

Family

ID=6471239

Family Applications (1)

Application Number Title Priority Date Filing Date
UA93002241A UA27099C2 (uk) 1992-10-23 1993-10-21 Склад для протипухлиhhої терапії у формі розчиhу, спосіб його одержаhhя та лікарський засіб для протипухлиhhої терапії

Country Status (14)

Country Link
US (1) US5446033A (uk)
EP (1) EP0593897B1 (uk)
JP (1) JPH06227987A (uk)
CN (1) CN1052878C (uk)
AT (1) ATE136784T1 (uk)
CA (1) CA2109053C (uk)
DE (2) DE4235911A1 (uk)
DK (1) DK0593897T3 (uk)
EG (1) EG20234A (uk)
ES (1) ES2086168T3 (uk)
GR (1) GR3020045T3 (uk)
RU (1) RU2114624C1 (uk)
SG (1) SG48779A1 (uk)
UA (1) UA27099C2 (uk)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6828415B2 (en) 1993-02-19 2004-12-07 Zentaris Gmbh Oligopeptide lyophilisate, their preparation and use
FR2729050A1 (fr) * 1995-02-23 1996-07-12 Oreal Compositions resistant a la degradation microbienne
US6278004B1 (en) 1996-11-06 2001-08-21 Aventis Pharma Deutschland Gmbh Stabilized phospholipidic composition
DE10028638A1 (de) * 2000-06-09 2001-12-20 Schuelke & Mayr Gmbh Lagerstabile Zusammensetzungen von Glycerinmonoalkylethern
US7041302B2 (en) * 2001-01-09 2006-05-09 Biother Corporation Therapeutic modulation of the tumor inflammatory response
DE10313272A1 (de) * 2003-03-24 2004-10-21 Baxter Healthcare S.A. Verwendung von Miltefosine zur Behandlung von aktinischer oder multiplen aktinischer Keratosen
NZ597560A (en) * 2009-07-09 2013-05-31 Paul Meng Liquid pharmaceutical form of alkylphosphocholine and method of preparing same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5008294A (en) * 1985-02-11 1991-04-16 Chemex Pharmaceuticals, Inc. Methods of treating tumors with compositions of catecholic butanes
DE3343530A1 (de) * 1983-12-01 1985-06-13 Max Planck Gesellschaft Arzneimittel mit verbesserter penetration der gewebsmembran
IE59778B1 (en) * 1985-12-04 1994-04-06 Max Planck Gesellschaft Medicament with anti-tumour action containing hexadecylphosphocholine
EP0916343A1 (de) * 1989-09-27 1999-05-19 ASTA Medica Aktiengesellschaft Verwendung von Alkylphosphorsäure-Verbindungen zur Bekämpfung von Psoriasis-Erkrankungen

Also Published As

Publication number Publication date
GR3020045T3 (en) 1996-08-31
RU2114624C1 (ru) 1998-07-10
CN1052878C (zh) 2000-05-31
ATE136784T1 (de) 1996-05-15
JPH06227987A (ja) 1994-08-16
CN1090174A (zh) 1994-08-03
EP0593897B1 (de) 1996-04-17
EP0593897A1 (de) 1994-04-27
US5446033A (en) 1995-08-29
SG48779A1 (en) 1998-05-18
EG20234A (en) 1998-05-31
ES2086168T3 (es) 1996-06-16
DK0593897T3 (da) 1996-05-13
DE4235911A1 (de) 1994-04-28
CA2109053A1 (en) 1994-04-24
DE59302251D1 (de) 1996-05-23
CA2109053C (en) 2004-02-10

Similar Documents

Publication Publication Date Title
UA39158C2 (uk) Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі
AP9801392A0 (en) Concentrated antibody preparation.
DK0708772T3 (da) Imidazo[4,5,-c]pyridin-4-aminer
MX9702932A (es) L-ribofuranosilnucleosidos.
ES2102196T3 (es) Periferializacion de celulas pluripotenciales hematopoyeticas.
ES8603425A1 (es) Un procedimiento para preparar 1-amino-4-nitro-acridinonas sustituidas
MY109990A (en) Microfluidised particles of atovaquone and pharmaceutical preparation thereof
NZ314839A (en) 1,25-Dihydroxy-16,23Z-diene-20-epi-16-ene-cholecalciferol (Vitamin D3) analogues
IL146125A0 (en) Novel quinones as disease therapies
PH21102A (en) Improvements in or relating to benzothiophene derivatives as antiastmatic agents
BG102250A (en) The use of marigold-extracted glycosides for the treatment of psoriasis
IL151628A0 (en) Combination therapies with vascular damaging activity
ZA943553B (en) Tri(platinum) complexes
MY128260A (en) Cyclopentane-and-pentene-b-amino acids
ZA855822B (en) Pharmaceutical compositions for the treatment of involutional brain syndromes and mental decay
DE69120287D1 (en) Aminosulfonylharnstoff-acat-inhibitoren
UA27099C2 (uk) Склад для протипухлиhhої терапії у формі розчиhу, спосіб його одержаhhя та лікарський засіб для протипухлиhhої терапії
IL99778A0 (en) Compositions for the treatment of cell proliferation disorders
PL315127A1 (en) Deuterised biologically active substances for percutaneous administration
MX9702926A (es) L-eritrosilnucleosidos.
NO983177L (no) Anvendelse av 1-enantiomeren av centkroman til fremstilling av et farmasaytisk preparat for behandling eller profylakse av brystkreft
GR3035982T3 (en) Terpenoidic derivatives (sarcodictyins) useful as antitumor agents
IL131478A0 (en) Methods for treatment of scar tissue
HUT41002A (en) Process for preparing anticonvulsives
ES8404693A1 (es) Procedimiento de preparacion de nuevos amino-14 esteroides.